Psoriatic Arthritis
📧 Sign up to get email alerts when something new happens for Psoriatic Arthritis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-12-19FDA Approved: SIMPONI — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for SIMPONI (golimumab) submitted by Janssen Biotech, Inc.
-
CLINICAL_TRIALS trial_result · 2014-11-21Clinical Trial Update: Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject Etanercept [Phase 3]
Phase 3 trial evaluating the ability of subjects with rheumatoid arthritis or psoriatic arthritis to effectively use a reusable autoinjector…
-
FDA approval · 2014-10-08FDA Approved: OTREXUP — Supplemental Application (Antares Pharma, Inc.)
FDA approved a supplemental application for OTREXUP (methotrexate) submitted by Antares Pharma, Inc.
-
FDA approval · 2014-09-30FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approved Humira's supplemental application submitted by Cordavis Limited. The approval acts as a supplemental approval to the existing H…
-
FDA approval · 2014-09-23FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA approved a supplemental application for Humira (adalimumab) to add Cordavis Limited as a supplier. This action supports continued av…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-09-23Clinical Trial Update: A 24 Week Open Label Study of the Utility of Adalimumab in Active Axial Forms of Psoriatic Arthritis
A 24-week open-label study evaluated the use of adalimumab for active axial psoriatic arthritis; the trial has been completed.
-
FDA approval · 2014-09-19FDA Approved: OTEZLA — Supplemental Application (Amgen, Inc)
The FDA approved a supplemental application for OTEZLA (apremilast) submitted by Amgen.
-
CLINICAL_TRIALS trial_result · 2014-09-18Clinical Trial Update: A Placebo-controlled Study With an Extension Examining the Safety and Efficacy of Alefacept in Psoriatic Arthritis [Phase 2]
A Phase 2 placebo-controlled study of alefacept in psoriatic arthritis, with an extension to evaluate long-term safety and efficacy.
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA) [Phase 3]
Phase 3 trial update on apremilast for active psoriatic arthritis, reporting efficacy and safety results.
-
FDA approval · 2014-07-28FDA Approved: OTEZLA — Supplemental Application (Amgen, Inc)
The FDA approved a supplemental application for OTEZLA (apremilast) from Amgen, potentially expanding or updating its label.
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: Exploratory Study on Quality of Life in Patient With Moderate Psoriasis and Moderate Psoriatic Arthritis
An exploratory clinical trial assessing quality of life in patients with moderate psoriasis and moderate psoriatic arthritis, which has comp…
-
CLINICAL_TRIALS trial_result · 2014-07-11Clinical Trial Update: Metformin in Psoriatic Arthritis [NA]
A clinical trial evaluating metformin for psoriatic arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-11Clinical Trial Update: Effect of Exercise and Diet on Psoriatic Arthritis [NA]
A completed clinical trial evaluated the effects of exercise and diet on psoriatic arthritis.
-
FDA approval · 2014-05-30FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA approved a supplemental application for Humira (adalimumab) submitted by Cordavis Limited under BLA125057.
-
CLINICAL_TRIALS trial_result · 2014-05-20Clinical Trial Update: PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis [Phase 3]
Phase 3 trial update for apremilast in active psoriatic arthritis reports efficacy and safety results.
-
CLINICAL_TRIALS trial_result · 2014-05-20Clinical Trial Update: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis [Phase 3]
Phase 3 clinical trial update on apremilast for active psoriatic arthritis reporting efficacy and safety results.
-
CLINICAL_TRIALS trial_result · 2014-05-19Clinical Trial Update: PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis [Phase 3]
Phase 3 trial update for apremilast in active psoriatic arthritis with efficacy and safety data.
-
CLINICAL_TRIALS trial_result · 2014-05-07Clinical Trial Update: Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis [Phase 4]
A Phase 4 study evaluating the impact of a biological treatment on blood pressure and endothelial function in patients with rheumatoid arthr…
-
CLINICAL_TRIALS trial_result · 2014-04-24Clinical Trial Update: REPArE: Rating Evaluations in Psoriatic Arthritis (PsA) With Etanercept (Enbrel®) [Phase 4]
Phase 4 trial REPArE evaluated etanercept (Enbrel) for psoriatic arthritis; the study has completed with results posted in 2014.
-
FDA approval · 2014-03-21FDA Approved: OTEZLA — Original Application (Amgen, Inc)
FDA approved OTEZLA (apremilast) from Amgen in its Original Application for the treatment of plaque psoriasis and psoriatic arthritis.
-
CLINICAL_TRIALS trial_result · 2014-03-13Clinical Trial Update: A Study of the Safety and Effectiveness of Ustekinumab in Patients With Psoriatic Arthritis [Phase 3]
Phase 3 trial results evaluate the safety and effectiveness of ustekinumab in patients with psoriatic arthritis; results were posted in 2014…
-
FDA approval · 2014-03-04FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for ustekinumab from Janssen Biotech, Inc., leading to changes in its labeling/approved use.
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents [Phase 3]
A Phase 3 clinical trial update reporting the safety and efficacy of ustekinumab in adults with psoriatic arthritis, including patients with…
-
CLINICAL_TRIALS trial_result · 2014-02-26Clinical Trial Update: Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists
Completed clinical trial evaluating the safety and efficacy of etanercept in patients with psoriatic arthritis treated by rheumatologists. R…
-
CLINICAL_TRIALS trial_result · 2014-02-26Clinical Trial Update: Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists
A completed clinical trial evaluated the safety and efficacy of etanercept in psoriatic arthritis patients treated by dermatologists, with r…